ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects

References

• Bai S, Nasser MW, Wang B, et al. (2009). MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 284:32015–27
   PubMed Web of Science ®Google Scholar
• Bekris LM, Galloway NM, Millard S, et al. (2011). Amyloid precursor protein (APP) processing genes and cerebrospinal fluid APP cleavage product levels in Alzheimer's disease. Neurobiol Aging 32:31
   PubMed Web of Science ®Google Scholar
• Bekris LM, Lutz F, Li G, et al. (2012). ADAM10 expression and promoter haplotype in Alzheimer's disease. Neurobiol Aging 33:2229.e1–9
   PubMed Web of Science ®Google Scholar
• Bernstein HG, Bukowska A, Krell D, et al. (2003). Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome. J Neurocytol 32:153–60
   PubMedGoogle Scholar
• Colciaghi F, Borroni B, Pastorino L, et al. (2002). [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients. Mol Med 8:67–74
   PubMed Web of Science ®Google Scholar
• Colciaghi F, Marcello E, Borroni B, et al. (2004). Platelet APP, ADAM 10 and BACE alterations in the early stages of Alzheimer disease. Neurology 62:498–501
   PubMed Web of Science ®Google Scholar
• Endres K, Fahrenholz F. (2012). Regulation of alpha-secretase ADAM10 expression and activity. Exp Brain Res 217:343–52
   PubMed Web of Science ®Google Scholar
• Gatta LB, Albertini A, Ravid R, Finazzi D. (2002). Levels of beta-secretase BACE and alpha-secretase ADAM10 mRNAs in Alzheimer hippocampus. Neuroreport 13:2031–3
   PubMed Web of Science ®Google Scholar
• Gorham P, Bark N, Bjorkhem I, et al. (2010). Platelet alpha- and beta-secretase activities are not significantly affected by dementia or mild cognitive impairment in Swedish patients. Curr Alzheimer Res 7:134–9
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. (2002). The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353–6
   PubMed Web of Science ®Google Scholar
• Hohsfield LA, Humpel C. (2015). Migration of blood cells to β-amyloid plaques in Alzheimer's disease. Exp Gerontol 65:8–15
   PubMed Web of Science ®Google Scholar
• Jorissen E, Prox J, Bernreuther C, et al. (2010). The disintegrin/metalloproteinase ADAM10 is essential for the establishment of the brain cortex. J Neurosci 30:4833–44
   PubMed Web of Science ®Google Scholar
• Kim M, Suh J, Romano D, et al. (2009). Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate α-secretase activity. Hum Mol Genet 18:3987–96
   PubMed Web of Science ®Google Scholar
• Kuhn PH, Wang H, Dislich B, et al. (2010). ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29:3020–32
   PubMed Web of Science ®Google Scholar
• Lammich S, Buell D, Zilow S, et al. (2010). Expression of the anti-amyloidogenic secretase ADAM10 is suppressed by its 5′-untranslated region. J Biol Chem 285:15753–60
   PubMed Web of Science ®Google Scholar
• Lichtenthaler SF. (2011). Alpha-secretase in Alzheimer's disease: molecular identity, regulation and therapeutic potential. J Neurochem 116:10–21
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–8
   PubMed Web of Science ®Google Scholar
• Manzine PR, Bram JMF, Barham EJ, et al. (2013). ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly. Dement Geriatr Cogn Disord 35:58–66
   PubMed Web of Science ®Google Scholar
• Marcello E, Saraceno C, Musardo S, et al. (2013). Endocytosis of synaptic ADAM10 in neuronal plasticity and Alzheimer's disease. J Clin Invest 123:2523–38
   PubMed Web of Science ®Google Scholar
• Marcinkiewicz M, Seidah NG. (2000). Coordinated expression of β-amyloid precursor protein and the putative β-secretase BACE and α-secretase ADAM10 in mouse and human brain. J Neurochem 75:2133–43
   PubMed Web of Science ®Google Scholar
• Meziane H, Dodart JC, Mathis C, et al. (1998). Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc Nat Acad Sci 95:12683–8
   PubMed Web of Science ®Google Scholar
• Morishima-Kawashima M, Ihara Y. (2002). Alzheimer's disease: β-amyloid protein and tau. J Neurosci Res 70:392–401
   PubMed Web of Science ®Google Scholar
• Persengiev S, Kondova I, Otting N, et al. (2011). Genome-wide analysis of miRNA expression reveals a potential role for miR-144 in brain aging and spinocerebellar ataxia pathogenesis. Neurobiol Aging 32:2316.e17–27
   PubMed Web of Science ®Google Scholar
• Petersen RC. (2004). Mild cognitive impairment as a diagnostic entity. J Intern Med 256:183–94
   PubMed Web of Science ®Google Scholar
• Prinzen C, Muller U, Endres K, et al. (2005). Genomic structure and functional characterization of the human ADAM10 promoter. FASEB J 19:1522–4
   PubMed Web of Science ®Google Scholar
• Reinhardt S, Schuck F, Grosgen S, et al. (2014). Unfolded protein response signaling by transcription factor XBP-1 regulates ADAM10 and is affected in Alzheimer's disease. FASEB J 28:978–97
   PubMed Web of Science ®Google Scholar
• Stein TD, Anders NJ, Decarli C, et al. (2004). Neutralization of transthyretin reverses the neuroprotective effects of secreted amyloid precursor protein (APP) in APPSw mice resulting in tau phosphorylation and loss of hippocampal neurons: support for the amyloid hypothesis. J Neurosci 24:7707–17
   PubMed Web of Science ®Google Scholar
• Tang K, Hynan LS, Baskin F, Rosenberg RN. (2006). Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease. J Neurol Sci 240:53–8
   PubMed Web of Science ®Google Scholar
• Tricarico C, Pinzan P, Bianchi S, et al. (2002). Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309:293–300
   PubMed Web of Science ®Google Scholar
• Tyler SJ, Dawbarn D, Wilcock GK, Allen SJ. (2002). Alpha- and beta-secretase: profound changes in Alzheimer's disease. Biochem Biophys Res Commun 299:373–6
   PubMed Web of Science ®Google Scholar
• Vandesompele J, De Preter K, Pattyn F, et al. (2002). Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034 (1--12)
   PubMed Web of Science ®Google Scholar